The Injection Is Made From You. That Is the Whole Problem.

Autologous is a quiet word doing enormous work. It means the injectate is manufactured from the patient — their blood, their marrow, their platelets, their growth factors. There is no supplier, no batch number, no quality control department. The raw material is whatever biology walked into the room.

Which makes the obvious question the one nobody asks before the appointment: what condition is the raw material in?

The confession that belongs at the front of this

Dr. Padda spent the first two decades of his career telling patients with a creeping A1C that it was not too bad, because that is what he had been taught to say. He was wrong, and he says so publicly, because the physiology he learned later changed how he treats pain rather than merely how he counsels about diet. Nobody gets to be the authority on metabolic disease without first admitting they misread it for twenty years.

What the tissue is actually being asked to do

A platelet concentrate delivers a payload of growth factors into a specific place and asks the local tissue to mount a repair response. Whether that response happens depends on the environment it lands in — locally, and systemically.

Two upstream drivers matter most here. The first is metabolic inflammation: a chronic, low-grade inflammatory state that keeps the body in a breakdown-dominant posture rather than a repair-dominant one. The second is insulin resistance and the hyperinsulinemia that accompanies it, which alters how tissue handles fuel and how blood vessels behave in the smallest arteries that supply tendon and cartilage.

Then the third factor, which is not biological at all. It is the shift schedule, the second job, the four hours of sleep, the food available on the way home at eleven at night, and — after an injury — the financial pressure of a claim that will not resolve. Those are not soft variables. Sleep restriction and chronic stress are among the most reliable ways to raise inflammatory markers in a human being, and they are the variables a clinic never asks about. The longer version of that argument.

What the evidence supports, and what it does not

State this carefully, because it is where enthusiasm outruns data.

Metabolic disease is firmly associated with the tendon conditions people get injected for. A meta-analysis of risk factors for rotator cuff tendinopathy found diabetes associated with roughly a doubling of the odds — an odds ratio of 2.24 — and age over 50 with an odds ratio of 3.31. That is about who develops the condition, not about who responds to treatment for it, and the distinction matters.

On response, the honest finding runs partly against the intuition. A secondary analysis of a randomized trial that compared PRP with microfragmented adipose tissue in knee osteoarthritis found body mass index inversely correlated with quality-of-life and daily-activity outcomes in the adipose group — and not in the PRP group. Forty-nine patients completed twelve months. It is one trial, and body mass index is a crude proxy for metabolic health rather than a measurement of it. But no one should tell you that trial data prove a metabolic workup improves your PRP result. It does not exist yet.

What the guidance documents do say is that the response depends on patient selection and on preparation quality, and that the field’s own reporting is too inconsistent to isolate variables like this. That is an argument for measuring more, not for measuring less.

So why measure it at all

Three reasons that do not depend on a trial that has not been run.

First, because the terrain is a separate disease and it does not politely wait outside. Someone with untreated insulin resistance who gets an excellent knee injection still has untreated insulin resistance, and it will decide things about the next twenty years that the knee will not.

Second, because it is the most common explanation for the patient who did everything right and stayed in pain. When appropriate structural treatment has been delivered accurately and the pain persists, the environment is the remaining variable worth interrogating.

Third, because it is objective. An injured person spends months being told their pain is subjective. High- sensitivity CRP, markers of insulin resistance, lipid particle measures and A1C are numbers on a page with dates attached, and numbers with dates behave differently in a claim file than adjectives do. Why objective data is the answer to that accusation.

What gets measured

A metabolic and inflammatory panel as the starting point: high-sensitivity CRP, markers of insulin resistance, lipid particle measures, A1C — read alongside sleep, nicotine exposure, medication list and the clinical examination. No single value decides anything. The pattern does.

What gets asked of the patient, and why it works

Every recommendation here carries a physiological reason, or it does not get made.

Load the tissue. Tendon and cartilage adapt to mechanical demand; unloaded tissue does not remodel usefully, and immobilization after an injury is one of the most common self-inflicted causes of a bad outcome. Progressive loading is the stimulus the injection is supposed to make tolerable.

Sleep, seriously. Insufficient restorative sleep is associated with higher cortisol and higher inflammatory markers, and a cortisol-dominant state favors breakdown over repair. This is the single most commonly ignored input after an injury, largely because pain wrecks sleep and nobody treats the sleep.

Nicotine. It constricts the small vessels that supply the tissue you are trying to heal. If only one change is going to happen this month, that is the one.

Change what the background inflammation is fed. Acellular carbohydrates and industrial seed oils are not a moral question; they are an input to the inflammatory state that the injectate has to work inside.

None of this is aftercare. Roughly half of the treatment plan in this practice is behavioral, and it is the half that decides whether the interventional half holds.

What this has to do with the claim

Two things, one helpful and one not.

The unhelpful one first: a documented metabolic condition is exactly the alternative explanation a defense expert reaches for. If your knee hurts and your A1C is 6.9, someone will argue the arthritis was metabolic and the collision incidental.

The helpful one: the counter-argument only exists if the terrain was measured and addressed. A record showing inflammatory and metabolic markers tracked over time, with a treatment plan aimed at them, converts the defense’s alternative explanation into a documented comorbidity that was identified and managed — which is a different conversation entirely. How causation gets argued when a pre-existing condition is in the file.

Frequently asked questions

Does having diabetes mean an orthobiologic injection will not work?

No. What the evidence shows is that metabolic disease is associated with developing tendon problems in the first place — a meta-analysis found diabetes roughly doubled the odds of rotator cuff tendinopathy — not that it predicts failure of treatment. It is a reason to treat both, not a reason to withhold either. Learn more: why the biological terrain governs recovery.

Is there proof that fixing my metabolic markers improves PRP results?

Not from a trial designed to answer that question. One randomized-trial analysis found body mass index correlated with outcomes after microfragmented adipose tissue but not after PRP. Metabolic care is done because the metabolic disease is real and treatable in its own right, and because it is the most common explanation for pain that persists after accurate structural treatment. Learn more: what the guidelines do and do not establish.

What tests are involved?

A metabolic and inflammatory panel is the starting point: high-sensitivity CRP, markers of insulin resistance, lipid particle measures and A1C, interpreted alongside sleep, nicotine exposure, medications and the clinical examination. No single value is decisive. Learn more: how the panel is read.

Is this saying my injury pain is my own fault?

No. Metabolic inflammation is a physiological state that occurs in people of every build, and it is driven as much by sleep, shift work, stress and the food environment as by anything a person chooses. It changes how tissue heals. It says nothing about blame. Learn more: the consequences of injury that never make it into the record.

Could the insurance company use my metabolic condition against me?

They can try, and the answer is documentation rather than concealment. A record that identifies the condition, tracks its markers over time and treats it turns an alternative explanation into a managed comorbidity. Learn more: how causation is argued when a pre-existing condition is in the file.

Where is Injury Experts located?

Injury Experts is at 4477 Woodson Rd, Suite 202, St. Louis, MO 63134, next to Lambert International Airport, serving the St. Louis region in Missouri and Illinois. Call (314) 887-5866 or text (314) 886-5902.

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine.

This article is for general education and is not medical advice. It does not create a physician–patient relationship. Do not start, stop, or change any medication — including opioid medication — without consulting your physician.